Cytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases
Cibele Pidorodeski Nagano, Cláudia Malheiros Coutinho-Camillo, Clovis Antônio Pinto, Fernando Augusto Soares, Filipa Santos, Isabel Fonseca, Silvia Vanessa Lourenço
Distant metastases from salivary gland tumors are considered infrequent: the incidence of distant metastases ranges from 24% to 61% according to different histotypes and to the site of the primary mass. The most common site of distant metastases due to salivary gland malignancies is the lung. From the pathology point of view, cytokeratins (CK) are important differentiation markers in salivary gland tumors, which are often used for the diagnostic process. Their employment also may be useful to identify and confirm the diagnosis of their distant metastases. We report the expression of CK in two cases of primary and metastatic adenoid cystic carcinoma (ACC) and their CK profiles of the primary and metastatic masses. Both patients—one male and one female—were diagnosed with an ACC cribriform and tubular, respectively, with lung metastases. In case 1, the metastatic mass presented the same histotype and CK profile of the primary tumor. For case 2, the metastatic lung mass was distinct from the primary mass (a solid ACC) and presented a different CK profile. Although salivary gland metastatic disease presents a poor prognosis, both patients reported herein are alive despite the presence of the disease in long-term follow-up. Therefore, the modifications seen in the CK profiles do not appear to be predictive of tumor behavior and outcome. The use of a CK profile seems to be useful to identify the nature of a distant mass and its possible correlations with a primary salivary gland tumor.
1. World Health Organization (WHO). International Agency for Research on Cancer (IARC). Tumours of the Salivary glands: World Health Organization Classification of tumours: pathology and Genetics of head and neck tumours. Lyon: IARC Press; 2005.
2. Bradley PJ. Distant metastases from salivary glands cancer. J Otorhinolaryngol Relat Spec. 2001;63(4):233-42. PMid:11408820. http://dx.doi.org/10.1159/000055748.
3. Namboodiripad A. A review: immunological markers for malignant salivary gland tumours. J Oral Biol Craniofac Res. 2014;4(2):127-34. PMid:25737930. http://dx.doi.org/10.1016/j.jobcr.2014.05.003.
4. Ali S, Bryant R, Palmer FL, et al. Distant metastasis in patients with carcinoma of the major salivary glands. Ann Surg Oncol. 2015;22(12):4014-9. PMid:25743328. http://dx.doi.org/10.1245/s10434-015-4454-y.
5. Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE. Salivary gland carcinomas. Oral Maxillofac Surg. 2012;16(3):267-83. PMid:22842859. http://dx.doi.org/10.1007/s10006-012-0350-9.
6. Simpson RHW, Skalova A, Di Palma S, Leivo I. Recent advances in the diagnostic pathology of salivary carcinomas. Virchows Arch. 2014;465(4):371-84. PMid:25172327. http://dx.doi.org/10.1007/s00428-014-1639-x.
7. Gupta R, Balasubramanian D, Clark JR. Salivary gland lesions: recent advances and evolving concepts. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(6):661-74. PMid:25840511. http://dx.doi.org/10.1016/j.oooo.2015.02.481.